Literature DB >> 17968795

Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.

M Lacher1, K Schneider, R Dalla Pozza, D V Schweinitz.   

Abstract

Prostaglandin E1 (PGE1) is widely used in neonates with cyanotic congenital heart disease who depend on the patency of the ductus arteriosus for oxygenation. Side effects of prostaglandin therapy are common and include respiratory depression, generalized flushing, and cardiovascular and neurological effects. Little is known about the complex effects on the gastrointestinal tract. We report on an infant with gastric outlet obstruction after long-term prostaglandin administration. At the age of 1 month, feeding problems developed with projectile vomiting. Ultrasonography showed progressive elongation of the antropyloric channel without wall thickening, which was causing gastric outlet obstruction. Three days after cardiac surgery and cessation of prostaglandin therapy, the infant fed normally and rapidly gained weight. The clinical signs in such patients can mimic hypertrophic pyloric stenosis. Therefore, the sonographic findings should not be confused with pyloric wall thickening to avoid a false diagnosis and unnecessary surgery. The symptoms diminish with cessation of the prostaglandin therapy after a corrective cardiac operation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968795     DOI: 10.1055/s-2007-965422

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  4 in total

1.  Transient hypertrophic pyloric stenosis due to prostoglandin infusion.

Authors:  T Soyer; S Yalcin; D Bozkaya; S Yiğit; F C Tanyel
Journal:  J Perinatol       Date:  2014-10       Impact factor: 2.521

2.  Association of prematurity with the development of infantile hypertrophic pyloric stenosis.

Authors:  Christopher M Stark; Philip L Rogers; Matthew D Eberly; Cade M Nylund
Journal:  Pediatr Res       Date:  2015-05-07       Impact factor: 3.756

3.  Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis.

Authors:  Tina Perme; Senja Mali; Ivan Vidmar; Diana Gvardijančič; Robert Blumauer; David Mishaly; Iztok Grabnar; Gregor Nemec; Stefan Grosek
Journal:  Ups J Med Sci       Date:  2013-03-22       Impact factor: 2.384

Review 4.  Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.

Authors:  Smita Akkinapally; Shilpa G Hundalani; Madhulika Kulkarni; Caraciolo J Fernandes; Antonio G Cabrera; Binoy Shivanna; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2018-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.